Results are, overall, positive and reassuring, but further work is needed to address rise in some less common types of cancer, say experts Cases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also ...

Particularly those approved through “fast track” pathways Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited (“fast track”) pathways, finds a study published by The BMJ today. And despite pharmaceutical industry claims that high drug prices are ...

Increased risk lasts for at least 25 years after diagnosis, suggesting longer term monitoring is needed Women who are diagnosed with ductal carcinoma in situ (DCIS) outside the NHS breast screening programme are around four times as likely to develop invasive breast cancer and to die from breast cancer than ...

Absolute risk of cervical cancer remains low, but results show importance of regular checks for women having active surveillance Actively monitoring abnormal cells (lesions) that line the cervix rather than removing them straight away is associated with an increased long term risk of cervical cancer, suggests a study published by The ...

Findings raise quality of care concerns about this common practice, say researchers Patients with cancer whose oncologist receives payments from industry appear more likely to receive some non-recommended and low value treatments, finds a US study published by The BMJ today. This finding raises potential concerns about quality of care, and the ...